The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Operation Supplement Safety (OPSS) Bethesda MD Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks